Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05256641
Title Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

marginal zone B-cell lymphoma

lymphoplasmacytic lymphoma

follicular lymphoma

Waldenstroem's macroglobulinemia

B-cell lymphoma

Therapies

Acalabrutinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA / Jonsson Comprehensive Cancer Center Los Angeles California 90095 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
University of Oklahoma Oklahoma City Oklahoma 73190 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field